Avant Technologies Inc. (OTCQB: AVAI) and joint venture partner Ainnova Tech Inc. announced they have revised their clinical trial protocol ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE